December 13, 2018
What can we gain from looking at the outliers?: An investigation into long and short-term ovarian cancer survivors

Researchers investigate the clinical, molecular and microenvironment factors that contribute to extreme therapy response and resistance in ovarian cancer patients
Some patients with high-grade serous ovarian cancer (HGSOC) respond exceptionally well to therapy, while others experience rapid disease relapse. The mechanisms behind these disparate outcomes are poorly understood, but a group of researchers based at the Princess Margaret Cancer Centre (PM) supported by OICR’s Ovarian Cancer Translational Research Initiative (TRI) are working to change that.
Continue reading – What can we gain from looking at the outliers?: An investigation into long and short-term ovarian cancer survivors